Literature DB >> 7836951

Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS.

M Aoki1, M Ogasawara, Y Matsubara, K Narisawa, S Nakamura, Y Itoyama, K Abe.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurological disorder that results in relentless damage to the motor neuron system. Although about 5-10% of cases are familial, the pathophysiologic process of ALS remains unknown. We identified a novel point mutation A to G in exon 2 of the Cu/Zn SOD gene, resulting in an amino acid substitution of histidine46 by arginine (H46R), in two Japanese familial ALS (FALS) families. The segregations of the mutation were evident. The enzymatic activities of Cu/Zn SOD of peripheral red blood cell lysate were reduced to about 80% in the affected members, compared with other non-affected family members. The patients in these families are clinically characterized by relative late onset, initial involvement in lower extremities, relative rare impairment of bulbar muscles and much slow progression of muscular weakness and atrophy, compared with other Japanese FALS cases who have no mutation in the Cu/Zn SOD gene. These findings suggest that the H46R mutation in Cu/Zn SOD gene is highly related to this unique subtype of FALS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7836951     DOI: 10.1016/0022-510x(94)90097-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

1.  Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg.

Authors:  Svetlana Antonyuk; Jennifer Stine Elam; Michael A Hough; Richard W Strange; Peter A Doucette; Jorge A Rodriguez; Lawrence J Hayward; Joan Selverstone Valentine; P John Hart; S Samar Hasnain
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

2.  Disease-associated mutations at copper ligand histidine residues of superoxide dismutase 1 diminish the binding of copper and compromise dimer stability.

Authors:  Jiou Wang; Amy Caruano-Yzermans; Angela Rodriguez; Jonathan P Scheurmann; Hilda H Slunt; Xiaohang Cao; Jonathan Gitlin; P John Hart; David R Borchelt
Journal:  J Biol Chem       Date:  2006-11-08       Impact factor: 5.157

Review 3.  Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.

Authors:  A Radunovíc; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

Review 4.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

5.  Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease.

Authors:  M Nagai; M Aoki; I Miyoshi; M Kato; P Pasinelli; N Kasai; R H Brown; Y Itoyama
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

6.  Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability.

Authors:  C Bergeron; C Petrunka; L Weyer
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

Review 7.  Amyotrophic lateral sclerosis: human challenge for neuroscience.

Authors:  L P Rowland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis.

Authors:  P J Hart; H Liu; M Pellegrini; A M Nersissian; E B Gralla; J S Valentine; D Eisenberg
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

9.  Molecular analyses of the Cu/Zn superoxide dismutase gene in patients with familial amyotrophic lateral sclerosis (ALS) in Japan.

Authors:  M Aoki; K Abe; Y Itoyama
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

Review 10.  Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments.

Authors:  J de Belleroche; R Orrell; A King
Journal:  J Med Genet       Date:  1995-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.